Tech Moves: Dendreon taps new CEO; Anthony Bay lands at Amazon; Globys; Limeade; Allyis; and much more

Mitchell Gold

Dendreon CEO Mitchell Gold is handing over the reins of the Seattle biotechnology company to board member and former Savient Pharmaceuticals CEO John Johnson. Shares of Dendreon, which have falling 58 percent in the past year, gained more than six percent on the news. Gold, who has served as CEO since 2003, plans to serve… Read More…